XenaCare Holdings, Inc., a Florida based healthcare products company, today announced signing of an agreement with Renaissance Publishing LLC, for the private label marketing of three XenaCare clinical supplement products. XenaCare will furnish the finished products to Renaissance for marketing in the U.S., with Renaissance providing the packaging and branding. Renaissance is a multimillion dollar company with 150,000 customers to which XenaCare now has access.
XenaCare President and CEO, Frank Rizzo, commented on the agreement. “We are very pleased to be working with Renaissance for U.S. private label marketing of these proprietary clinical supplement products. They fit into Renaissance’s growing portfolio of anti-aging dietary supplements that promote increased health, well-being, and life expectancy and allow us to concentrate our efforts and resources on Cobroxin(TM). We believe that the Renaissance strategy of providing education about its products along with its direct response sales model will result in greater awareness and sales of these unique products and look forward to a successful relationship with Renaissance.”
XenaCare engages in the formulation, marketing, and distribution of a wide range of healthcare products, including over-the-counter pain medication, cholesterol control and cardiovascular clinical products, as well as lifestyle performance products. The company markets its products through the Internet, pharmacies, doctors’ offices, plus food and drug stores.
The company recently received the exclusive license to market and distribute Zeolite, from Mineral Sciences, used for cellular detoxification. Research suggests Zeolite ingredients may help with viral infection and support healthy blood sugar levels. In addition, it improves nutrient absorption, supports immune system function, and reduces symptoms related to allergies. XenaCare was also awarded U.S. marketing rights to Cobroxin, the first over-the-counter pain reliever clinically proven to treat chronic pain. Cobroxin is an all-natural, non-addictive pain medication, said to be clinically proven to be more effective than morphine.
For more information, visit the company’s website at www.XenaCareHoldings.com.
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment